Immunohistologic analysis of estrogen receptor expression in breast carcinoma precursor lesions

Breast Journal

Volumn 4, Issue 6, 1998, Pages 447-451

  Visscher, Daniel W ^a,b   Padiyar, Niru ^a   Long, Dan ^a   Tabaczka, Pam ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast carcinoma; Estrogen receptor; Proliferative breast disease

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST HYPERPLASIA; CANCER INVASION; CARCINOMA IN SITU; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRECANCER; STAINING;

EID: 0032417681     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.1998.460447.x     Document Type: Article

References (6)

1. Jordan VC. "Studies on the estrogen receptor in breast cancer" - 20 years as a target for the treatment and prevention of cancer. Breast Cancer Res Treat 1995;36:267-85.
2. Bur ME, Zimarowski MJ, Schnitt SJ, Baker S, Lew R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 1992;69:1174-81.
3. Allred DC, O'Connell P, Fuqua SA, Osborne CK. Immunohistochemical studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:13-18.
4. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Allred DC. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:5-12.
5. Mori T, Morimoto T, Komaki K, Monden Y. Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer. Cancer 1991;68:532-37.
6. Allred DC. Prognostic and predictive factors in breast cancer assessed by immunohistochemistry. Breast Pathology Long Course, Supplement. USCAP Annual Meeting, March 5, 1997, Orlando, Florida.